A detailed history of Covington Capital Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Covington Capital Management holds 70,742 shares of BMY stock, worth $4.16 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
70,742
Previous 78,078 9.4%
Holding current value
$4.16 Million
Previous $6.01 Million 16.35%
% of portfolio
0.02%
Previous 0.24%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $953 - $563,698
-7,336 Reduced 9.4%
70,742 $5.03 Million
Q2 2022

Jul 08, 2022

SELL
$72.62 - $79.98 $744,500 - $819,954
-10,252 Reduced 11.61%
78,078 $6.01 Million
Q1 2022

May 13, 2022

SELL
$61.48 - $73.72 $50,106 - $60,081
-815 Reduced 0.91%
88,330 $6.45 Million
Q4 2021

Feb 16, 2022

SELL
$53.63 - $62.52 $2.14 Million - $2.49 Million
-39,868 Reduced 30.9%
89,145 $5.56 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $354,428 - $415,166
-5,990 Reduced 4.44%
129,013 $7.63 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $957,871 - $1.04 Million
-15,472 Reduced 10.28%
135,003 $9.02 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $803,760 - $903,993
-13,545 Reduced 8.26%
150,475 $9.5 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $90,074 - $102,070
1,560 Added 0.96%
164,020 $10.2 Million
Q3 2020

Nov 16, 2020

BUY
$57.43 - $63.64 $150,122 - $166,354
2,614 Added 1.64%
162,460 $9.8 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $216,758 - $253,411
3,954 Added 2.54%
159,846 $9.4 Million
Q1 2020

May 13, 2020

SELL
$46.4 - $67.43 $173,350 - $251,918
-3,736 Reduced 2.34%
155,892 $8.69 Million
Q4 2019

Feb 18, 2020

BUY
$49.21 - $64.19 $1.61 Million - $2.1 Million
32,678 Added 25.74%
159,628 $10.2 Million
Q3 2019

Nov 18, 2019

SELL
$42.77 - $50.71 $856,469 - $1.02 Million
-20,025 Reduced 13.62%
126,950 $6.44 Million
Q2 2019

Aug 15, 2019

BUY
$44.62 - $49.34 $105,437 - $116,590
2,363 Added 1.63%
146,975 $6.67 Million
Q1 2019

May 15, 2019

SELL
$45.12 - $53.8 $32,711 - $39,005
-725 Reduced 0.5%
144,612 $6.9 Million
Q4 2018

Feb 15, 2019

BUY
$48.76 - $63.23 $849,594 - $1.1 Million
17,424 Added 13.62%
145,337 $7.56 Million
Q3 2018

Nov 15, 2018

BUY
$55.19 - $62.25 $1.33 Million - $1.5 Million
24,095 Added 23.21%
127,913 $7.94 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $2.06 Million - $2.57 Million
40,854 Added 64.88%
103,818 $5.75 Million
Q1 2018

May 11, 2018

BUY
$59.92 - $68.98 $182,756 - $210,389
3,050 Added 5.09%
62,964 $3.98 Million
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $103,216 - $112,532
1,722 Added 2.96%
59,914 $3.67 Million
Q3 2017

Nov 14, 2017

SELL
$55.23 - $63.74 $180,491 - $208,302
-3,268 Reduced 5.32%
58,192 $3.71 Million
Q2 2017

Aug 16, 2017

BUY
N/A
61,460
61,460 $3.43 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Covington Capital Management Portfolio

Follow Covington Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covington Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Covington Capital Management with notifications on news.